Last update: May 10th, 2024

Salpingo-oophorectomy

• Uptake of RRSO: https://pubmed.ncbi.nlm.nih.gov/27430397/ 

Salpingectomy with delayed oophorectomy

• Acceptability of salpingectomy with delayed oophorectomy: https://pubmed.ncbi.nlm.nih.gov/24582866/ 
• Patients' and professionals' perspective: https://pubmed.ncbi.nlm.nih.gov/25560807/ 
• TUBA study protocol (NCT02321228): https://pubmed.ncbi.nlm.nih.gov/26286255/
• Acceptability and safety of salpingectomy: https://pubmed.ncbi.nlm.nih.gov/29735278/ 
• TUBA-WISP II study protocol (NCT04294927): https://pubmed.ncbi.nlm.nih.gov/37045546/
• Thesis 'Prevention and etiology of serous cancer of the female genital tract' by Miranda Steenbeek: Thesis 
• Thesis 'Optimizing risk-reducing care for women at high inherited risk for ovarian cancer: The potential of the fallopian tubes' by Majke van Bommel: Thesis
• TUBA-WISP II: Is een tubectomie met uitgestelde ovariectomie oncologisch veilig?: TUBA-WISP II: is een tubectomie met uitgestelde ovariëctomie oncologisch veilig? - NTVO (in Dutch, English summary available)

Cancer risks

• Estimating safety of salpingectomy with delayed oophorectomy: https://pubmed.ncbi.nlm.nih.gov/27159752/ 
• Peritoneal carcinomatosis after RRSO, review: https://pubmed.ncbi.nlm.nih.gov/29315498/ 
• Risk of peritoneal carcinomatosis after RRSO, individual patient data meta-analysis: https://pubmed.ncbi.nlm.nih.gov/35302882/ 
• Contraceptives and cancer risks among BRCA carriers: https://pubmed.ncbi.nlm.nih.gov/36383189/

Early ovarian cancer detection

• CA125 as early detection in women at increased familial risk: https://pubmed.ncbi.nlm.nih.gov/28143870/ 
• TP53 as biomarker for early detection: https://pubmed.ncbi.nlm.nih.gov/28637689/ 
• Mutation analysis along the Mullerian tract to detect ovarian cancer: pubmed.ncbi.nlm.nih.gov/36384753/ 

Decision making

• Satisfaction with ovarian cancer risk-reducing strategies: https://pubmed.ncbi.nlm.nih.gov/21656744/ 
• Factors influencing decision making: https://pubmed.ncbi.nlm.nih.gov/30479086/ 
• Development of a decision aid: https://pubmed.ncbi.nlm.nih.gov/29281161/ 
• Recommendations and choices for BRCA carriers, review: https://pubmed.ncbi.nlm.nih.gov/29466291/  
• Evaluation of the decision aid: https://pubmed.ncbi.nlm.nih.gov/34456057/ 

Quality of life

• Self-compassion, physical fitness and climacteric symptoms after RRSO: https://pubmed.ncbi.nlm.nih.gov/29290209/ 
• Demoralization after RRSO: https://pubmed.ncbi.nlm.nih.gov/28279121/ 
• Impact of medical choices on quality of life, review: https://pubmed.ncbi.nlm.nih.gov/26299336/ 
• Menopause-related quality of life (first results of TUBA study): https://pubmed.ncbi.nlm.nih.gov/34081085/ 
• Sexual functioning (first results of WISP study (NCT02760849)) - in progress 
• Cancer worry among BRCA pathogenic variant carriers: https://pubmed.ncbi.nlm.nih.gov/34997316/ 

Pathological aspects

• Role of fallopian tubes in ovarian cancer, review: https://pubmed.ncbi.nlm.nih.gov/28007588/ 
• Salpingectomy to reduce ovarian cancer risk, review: https://pubmed.ncbi.nlm.nih.gov/25586903/ 
• Does ovarian cancer start in the fallopian tubes?: https://pubmed.ncbi.nlm.nih.gov/29676714/ 
• Recommendations for diagnosing STIC, review: https://pubmed.ncbi.nlm.nih.gov/34850262/ 
• Consensus based recommendations for diagnosing STIC, Delphi study: https://pubmed.ncbi.nlm.nih.gov/36939551/

Cardiovascular aspects

• Cardiovascular risk among BRCA carriers, review: https://pubmed.ncbi.nlm.nih.gov/27451331/ 
• Consequence of BRCA pathogenic variant on cardiovascular risk, review: https://pubmed.ncbi.nlm.nih.gov/24529552/ 
• Subclinical atherosclerosis after RRSO: https://pubmed.ncbi.nlm.nih.gov/33229237/ 

Genetic aspects